We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock

Delisted

GRNA was delisted on the 21st of July, 2023.

68 hedge funds and large institutions have $173M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

6% more capital invested

Capital invested by funds: $163M → $173M (+$9.8M)

0% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 15

3% less funds holding

Funds holding: 7068 (-2)

Holders
68
Holders Change
-2
Holders Change %
-2.86%
% of All Funds
1.05%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
14
Reduced
11
Closed
15
Calls
$496K
Puts
Net Calls
+$496K
Net Calls Change
+$496K
Name Holding Trade Value Shares
Change
Change in
Stake
HCM
1
Highbridge Capital Management
New York
$18.9M +$1.15M +115,776 +6%
FTCM
2
Fir Tree Capital Management
New York
$10.6M +$2.61M +262,199 +33%
Hudson Bay Capital Management
3
Hudson Bay Capital Management
Connecticut
$9.92M
KC
4
Kryger Capital
United Kingdom
$8.86M +$8.88M +893,090 New
WAM
5
Weiss Asset Management
Massachusetts
$8.77M +$6.09M +612,323 +225%
Marshall Wace
6
Marshall Wace
United Kingdom
$7.8M +$7.81M +786,134 New
MF
7
Magnetar Financial
Illinois
$6.51M -$175K -17,610 -3%
AC
8
Aristeia Capital
Connecticut
$6.4M
CH
9
CVI Holdings
Delaware
$5.64M +$198K +19,952 +4%
KC
10
Kepos Capital
New York
$4.71M +$2.49M +250,000 +111%
Millennium Management
11
Millennium Management
New York
$4.68M +$1.32M +133,203 +39%
WP
12
Woodline Partners
California
$4.46M
RL
13
RPO LLC
Connecticut
$4.28M +$4.29M +431,565 New
SCM
14
Shaolin Capital Management
Florida
$4.07M
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$4M +$1.2M +121,019 +43%
Balyasny Asset Management
16
Balyasny Asset Management
Illinois
$3.97M
SCM
17
Saba Capital Management
New York
$3.74M
Alyeska Investment Group
18
Alyeska Investment Group
Illinois
$3.47M
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
19
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$3.22M
WCMNY
20
Westchester Capital Management (New York)
New York
$3M +$40 +4 +0%
AAA
21
Affinity Asset Advisors
New York
$2.98M
AC
22
Ayrton Capital
Connecticut
$2.98M +$2.98M +300,000 New
IPCP
23
Iron Park Capital Partners
New York
$2.65M +$2.66M +267,201 New
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$2.58M +$249K +25,000 +11%
UOC
25
UBS O'Connor
Illinois
$2.56M +$68.8K +6,922 +3%

GRNA Hedge Fund Activity: Q4 2021 in Review

68 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q4 2021, worth a combined $173M — up 6% from $163M a quarter earlier.

Fund positioning in GRNA was balanced in Q4 2021: 15 funds opened new positions, 15 closed out, 14 added to existing stakes and 11 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $7.81M. The largest seller was Telemark Asset Management, exiting entirely with an estimated $5.93M sold.

  • 68 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q4 2021, down from 70 in Q3 2021.
  • Funds reported $173M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q4 2021, up 6% quarter-over-quarter.
  • 15 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q4 2021 and 15 closed out, a net change of 0 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q4 2021 was Marshall Wace, an estimated $7.81M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q4 2021 was Telemark Asset Management, an estimated $5.93M sold.

Based on aggregated 13F filings for Q4 2021.